Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123685
Published online Jan 21, 2027. doi: 10.3748/wjg.123685
Published online Jan 21, 2027. doi: 10.3748/wjg.123685
Table 1 Clinicopathology and imaging features of the included patients, median (interquartile range)/n (%)
| Characteristics | Total (n = 417) | Training set (n = 292) | Validation set (n = 125) | P value |
| Time (months) | 48.00 (30.00, 71.00) | 47.00 (30.00, 71.00) | 50.00 (31.00, 71.00) | 0.568 |
| Age (years) | 0.847 | |||
| ≤ 60 | 269 (64.5) | 187 (64.0) | 82 (65.6) | |
| > 60 | 148 (35.5) | 105 (36.0) | 43 (34.4) | |
| Gender | 0.310 | |||
| Male | 211 (50.6) | 153 (52.4) | 58 (46.4) | |
| Female | 206 (49.4) | 139 (47.6) | 67 (53.6) | |
| Chemotherapy | 0.773 | |||
| No | 214 (51.3) | 148 (50.7) | 66 (52.8) | |
| Yes | 203 (48.7) | 144 (49.3) | 59 (47.2) | |
| Ki-67 index | 0.556 | |||
| ≤ 10 | 345 (82.7) | 239 (81.8) | 106 (84.8) | |
| > 10 | 72 (17.3) | 53 (18.2) | 19 (15.2) | |
| Mitotic count | 0.647 | |||
| ≤ 5 | 243 (58.3) | 168 (57.5) | 75 (60.0) | |
| 6-10 | 82 (19.7) | 56 (19.2) | 26 (20.8) | |
| > 10 | 92 (22.1) | 68 (23.3) | 24 (19.2) | |
| Location | 0.777 | |||
| Stomach | 271 (65.0) | 188 (64.4) | 83 (66.4) | |
| Non-stomach | 146 (35.0) | 104 (35.6) | 42 (33.6) | |
| Tumor size | 0.546 | |||
| ≤ 5 cm | 201 (48.2) | 140 (47.9) | 61 (48.8) | |
| 5.1-10 cm | 165 (39.6) | 113 (38.7) | 52 (41.6) | |
| > 10 cm | 51 (12.2) | 39 (13.4) | 12 (9.6) | |
| Boundary | 0.996 | |||
| Clear | 342 (82.0) | 240 (82.2) | 102 (81.6) | |
| Unclear | 75 (18.0) | 52 (17.8) | 23 (18.4) | |
| Contour | 0.288 | |||
| Regular | 133 (31.9) | 88 (30.1) | 45 (36.0) | |
| Irregular | 284 (68.1) | 204 (69.9) | 80 (64.0) | |
| Calcification | 0.230 | |||
| No | 346 (83.0) | 247 (84.6) | 99 (79.2) | |
| Yes | 71 (17.0) | 45 (15.4) | 26 (20.8) | |
| Ulceration | 0.272 | |||
| No | 307 (73.6) | 220 (75.3) | 87 (69.6) | |
| Yes | 110 (26.4) | 72 (24.7) | 38 (30.4) | |
| Growth pattern | 0.476 | |||
| Endoluminal | 88 (21.1) | 57 (19.5) | 31 (24.8) | |
| Exophytic | 201 (48.2) | 143 (49.0) | 58 (46.4) | |
| Mixed | 128 (30.7) | 92 (31.5) | 36 (28.8) | |
| Enhancement pattern | 0.703 | |||
| Homogeneous | 100 (24.0) | 68 (23.3) | 32 (25.6) | |
| Heterogeneous | 317 (76.0) | 224 (76.7) | 93 (74.4) | |
| Degree of enhancement | 0.643 | |||
| Mild | 90 (21.6) | 60 (20.5) | 30 (24.0) | |
| Moderate | 151 (36.2) | 105 (36.0) | 46 (36.8) | |
| Severe | 176 (42.2) | 127 (43.5) | 49 (39.2) | |
| EFDV | 0.717 | |||
| No | 153 (36.7) | 105 (36.0) | 48 (38.4) | |
| Yes | 264 (63.3) | 187 (64.0) | 77 (61.6) | |
| Peripheral fat infiltration | 0.632 | |||
| No | 315 (75.5) | 223 (76.4) | 92 (73.6) | |
| Yes | 102 (24.5) | 69 (23.6) | 33 (26.4) | |
| Direct organ invasion | 0.665 | |||
| No | 395 (94.7) | 278 (95.2) | 117 (93.6) | |
| Yes | 22 (5.3) | 14 (4.8) | 8 (6.4) |
Table 2 Exploration of independent influencing factors and construction of predictive models
| ModelLasso | Modelintegrated | |||
| HR (95%CI) | P value | HR (95%CI) | P value | |
| Tumor size (cm) | ||||
| ≤ 5 | Reference | |||
| 5.1-10 | 1.557 (0.718-3.379) | 0.262 | ||
| > 10 | 2.058 (0.792-5.353) | 0.139 | ||
| EFDV | ||||
| No | Reference | Reference | ||
| Yes | 4.250 (1.495-12.080) | 0.007 | 3.196 (1.115-9.157) | 0.031 |
| Peripheral fat infiltration | ||||
| No | Reference | Reference | ||
| Yes | 2.281 (1.144-4.551) | 0.019 | 1.229 (0.620-2.435) | 0.555 |
| Ki-67 (%) | ||||
| ≤ 10 | Reference | Reference | ||
| > 10 | 2.722 (1.484-4.993) | 0.001 | 1.889 (1.065-3.351) | 0.030 |
| RSF score | 1.173 (1.104-1.247) | < 0.001 | ||
- Citation: Zhao L, Zhao LM, Zheng XH, Zou K, Xie J, Liu XJ. Computed tomography-based nomogram for predicting recurrence of gastrointestinal stromal tumors. World J Gastroenterol 2027; 33(3): 123685
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/123685.htm
- DOI: https://dx.doi.org/10.3748/wjg.123685